A human milk oligosaccharide (HMO) called 2’FL has shown potential in improving the cognitive development of babies. The research, by investigators at Children’s Hospital Los Angeles and the University of California, San Diego, US was published yesterday in PLOS ONE. It marks the first study of its kind done in humans and comes as the […]
Human milk oligosaccharides (HMOs) are the “hot new thing” said an expert recently, as BASF announced the US launch of its 2’-FL (2’-fucosyllactose) ingredient, which is branded Prebilac. The company announced the launch of Prebilac at the recent SupplySide West show in Las Vegas. The ingredient was developed in partnership with biotechnology firm Glycosyn, which […]
Human milk oligosaccharides (HMOs) have extensive potential to offer a range of health benefits in products beyond infant formula, DuPont’s global business director for HMOs, Steen Lyck, said at Vitafoods Asia on Tuesday. Lyck was presenting findings from clinical trials on HMOs and their potential applications for not just infant health, but also adult and […]
FrieslandCampina DOMO’s new human milk oligosaccharide (HMO) ingredient, 2’-fucosyllactose (2’-FL), has been officially certified for use in infant formula in both European and US markets. The ingredient has received EU novel food approval and achieved GRAS (Generally Recognized as Safe) status from the Food and Drug Administration (FDA) in the US. The company reports that […]
